Showing 501-510 of 9990 results for "".
How to Safely and Successfully Re-open Your Practice
https://practicaldermatology.com/topics/practice-management/how-to-safely-and-successfully-re-open-your-practice/23296/Consider these tactics to ensure safety and educate your patients.Systemic Corticosteroids, Chronic Inflammatory Skin Disease, and COVID-19: What Do We Know?
https://practicaldermatology.com/topics/infections-infectious-disease/systemic-corticosteroids-chronic-inflammatory-skin-disease-and-covid-19-what-do-we-know/23615/An assessment of the risk of COVID-19 infection imposed by systemic corticosteroid use in the setting of chronic inflammatory skin disease.10 Tips for Managing Hidradenitis Suppurativa
https://practicaldermatology.com/issues/april-2025/10-tips-for-managing-hidradenitis-suppurativa/35602/In an effort to assist the working dermatologist, we have provided the following HS management guide, which supplies actionable insights into optimizing HS management, emphasizing the importance of individualized care, timely interventions, and collaboration with multidisciplinary teams.Backdoor Roth IRA Strategy in 2021
https://practicaldermatology.com/topics/practice-management/backdoor-roth-ira-strategy-in-2021/23480/As tax increases may come for high-income earners, we offer an effective step toward tax diversification.Snapshot: The Percentage of Dermatology Offices Open During the COVID-19 Pandemic
https://practicaldermatology.com/topics/practice-management/snapshot-the-percentage-of-dermatology-offices-open-during-the-covid-19-pandemic/23404/A survey of practices in two states sheds light on the impact of the novel coronavirus.First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/the-latest-on-systemic-agents-for-psoriasis/29073/The pharmacologic pipeline continues to produce strong options for systemic treatment of psoriasis. Practical Dermatology® spoke with Editorial Board member Jashin J. Wu, MD, FAAD, Founder and CEO of the Dermatology Research and Education Foundation, to discuss the latest treatment considerations wiBackdoor Roth IRA Strategy
https://practicaldermatology.com/topics/practice-management/backdoor-roth-ira-strategy/20428/An effective step toward tax diversification.Support for Population- Based Skin Cancer Screenings
https://practicaldermatology.com/topics/skin-cancer-photoprotection/support-for-population--based-skin-cancer-screenings/21675/A new study offers data to show that general skin cancer screenings by dermatologists and properly trained physicians can reduce morbidity and mortality.The Role of Hypnosis in Dermatology: More than Mere Suggestion
https://practicaldermatology.com/columns/clinical-focus-1/the-role-of-hypnosis-in-dermatology-more-than-mere-suggestion/23240/Hypnosis has shown promising results for patients who have had difficulty responding to more conventional therapies.